Gene · 2633
Papers1,970
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
301 to 320 of 1,970
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Shigella IpaH9.8 limits GBP1-dependent LPS release from intracytosolic bacteria to suppress caspase-4 activation. | Proc Natl Acad Sci U S A | 2023 | 37014865 | Swiss-Prot, curated | PubMed |
| Comparative study of GBP recruitment on two cytosol-dwelling pathogens, Francisella novicida and Shigella flexneri highlights differences in GBP repertoire and in GBP1 motif requirements. | Pathog Dis | 2023 | 37012222 | PubTator, text mining | PubMed |
| N6-methyladenosine modifications in maternal-fetal crosstalk and gestational diseases. | Front Cell Dev Biol | 2023 | 37009476 | PubTator, text mining | PubMed |
| Whole-genome sequencing and genomic analysis of Norduz goat (Capra hircus). | Mamm Genome | 2023 | 37004528 | PubTator, text mining | PubMed |
| Single cell RNA-seq resolution revealed CCR1+/SELL+/XAF+ CD14 monocytes mediated vascular endothelial cell injuries in Kawasaki disease and COVID-19. | Biochim Biophys Acta Mol Basis Dis | 2023 | 37001702 | PubTator, text mining | PubMed |
| Ellagitannins from Castanea sativa Mill. Leaf Extracts Impair H. pylori Viability and Infection-Induced Inflammation in Human Gastric Epithelial Cells. | Nutrients | 2023 | 36986236 | PubTator, text mining | PubMed |
| Cytotoxic Lymphocyte-Related Gene Signature in Triple-Negative Breast Cancer. | J Pers Med | 2023 | 36983639 | PubTator, text mining | PubMed |
| Development and Validation of a Prognostic Risk Model Based on Nature Killer Cells for Serous Ovarian Cancer. | J Pers Med | 2023 | 36983585 | PubTator, text mining | PubMed |
| Biomarker-Development Proteomics in Kidney Transplantation: An Updated Review. | Int J Mol Sci | 2023 | 36982359 | PubTator, text mining | PubMed |
| The Role of Different Immunocompetent Cell Populations in the Pathogenesis of Head and Neck Cancer-Regulatory Mechanisms of Pro- and Anti-Cancer Activity and Their Impact on Immunotherapy. | Cancers (Basel) | 2023 | 36980527 | PubTator, text mining | PubMed |
| Restricting genomic actions of innate immune mediators on fetal hematopoietic progenitor cells. | iScience | 2023 | 36950124 | PubTator, text mining | PubMed |
| Inactivation of interleukin-30 in colon cancer stem cells via CRISPR/Cas9 genome editing inhibits their oncogenicity and improves host survival. | J Immunother Cancer | 2023 | 36927528 | PubTator, text mining | PubMed |
| Guanylate-binding protein 1 inhibits nuclear delivery of pseudorabies virus by disrupting structure of actin filaments. | Vet Res | 2023 | 36918936 | PubTator, text mining | PubMed |
| RNF213 modulates γ-herpesvirus infection and reactivation via targeting the viral Replication and Transcription Activator. | Proc Natl Acad Sci U S A | 2023 | 36917666 | PubTator, text mining | PubMed |
| Host Blood Transcriptional Signatures as Candidate Biomarkers for Predicting Progression to Active Tuberculosis. | Tuberc Respir Dis (Seoul) | 2023 | 36912017 | PubTator, text mining | PubMed |
| Co-expression and interaction network analysis reveals dysregulated neutrophil and T-cell activation as the core mechanism associated with septic shock. | Front Genet | 2023 | 36911395 | PubTator, text mining | PubMed |
| Research Progresses and Applications of Fluorescent Protein Antibodies: A Review Focusing on Nanobodies. | Int J Mol Sci | 2023 | 36901737 | PubTator, text mining | PubMed |
| Urine Cell Transcriptomes Implicate Specific Renal Inflammatory Pathways Associated With Difficult-to-Control Hypertension. | J Am Heart Assoc | 2023 | 36892045 | PubTator, text mining | PubMed |
| Innate and Adaptive Immunity during SARS-CoV-2 Infection: Biomolecular Cellular Markers and Mechanisms. | Vaccines (Basel) | 2023 | 36851285 | PubTator, text mining | PubMed |
| Advancing personalized medicine for tuberculosis through the application of immune profiling. | Front Cell Infect Microbiol | 2023 | 36844400 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2633/papers?page=16